Document is current
Any future updates will be listed below
-
Authors
Murdocca, Michela
Pepe, Gerardo
Maccaroni, Serena
Spitalieri, Paola
Helmer-Citterich, Manuela
Novelli, Giuseppe
Sangiuolo, Federica https://orcid.org/0000-0002-6227-4248
-
Funding
Funding for this research was provided by:
Ministero dell' Università e della Ricerca Scientifica, PRIN (Prot. 20223WFJJ3)
European Union-NextGeneration EU (PNRR Next generation EU, M4-C2-I1.4, National Center for Gene Therapy, Drugs based on RNA Technology, Spoke 5 (CUP E83C22003200001))
European Union—NextGenerationEU (National Center for Gene Therapy, Drugs based on RNA Technology, CN3—Spoke 7 (code: CN00000041; PNRR—Mission 4, Component 2; Investment 1.4))
Università degli Studi di Roma Tor Vergata
- License Information
-
More Information
Article History
Received: 8 April 2025
Revised: 15 September 2025
Accepted: 18 September 2025
First Online: 13 October 2025
Declarations
:
: This study was conducted according to the principles expressed in the Declaration of Helsinki and approved by the institutional review board of the Bioethical Committee of Fondazione PTV, Tor Vergata Hospital (protocol n. 2932/2017). All patients provided written informed consent for sample collection and analysis.
: The authors declare no competing interests.
